All Viruses articles – Page 71
-
NewsBat immune genes protect against COVID and cancer
Bats have acquired remarkable traits throughout their evolution. They’re the only mammals that can fly, and they live much longer than other animals their size. But perhaps most impressive is their robust immune system. It protects bats from viruses that wreak havoc in humans, like COVID-19 or Ebola, and also ...
-
NewsLab-grown skin helps unlock secrets of mpox virus infection
A new model system for studying mpox virus infections in the laboratory is providing valuable insights into the virus’s mechanisms of attack on skin cells.
-
News Targeting a coronavirus ion channel could yield new Covid-19 drugs
Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation.
-
NewsAI tool can help forecast viral outbreaks
A new AI tool called EVEscape uses evolutionary and biological information to predict how a virus could change to escape the immune syste, and successfully predicted the most concerning new variants that occurred during the COVID-19 pandemic.
-
NewsNew UK projects to kickstart future vaccine development awarded £25m
Three UK projects designed to build our understanding of viruses and how the immune system reacts to different challenges will share £25m in new funding from UKRI.
-
NewsRemains of 1918 flu pandemic victims contradict belief that healthy young adults were particularly vulnerable
New analysis of the remains of victims of the 1918 influenza pandemic, which killed an estimated 50 million people worldwide, contradicts the widespread belief the flu disproportionately impacted healthy young adults.
-
NewsScientists discover ‘long colds’ may exist, as well as long Covid
A new study has found that people may experience long-term symptoms - or ‘long colds’ - after acute respiratory infections that test negative for COVID-19.
-
NewsPrior exposure to common virus shields against birth defects and miscarriage
A new study uncovers how pre-existing immunity to Cytomegalovirus (CMV) may significantly reduce the risk of birth defects and miscarriage during pregnancy, offering hope for a future vaccine.
-
NewsWastewater surveillance research provides 12-day lead time for RSV season
Researchers using wastewater surveillance over conventional indicators have predicted the start of the annual respiratory syncytial virus (RSV) season 12 days early, providing more lead time for hospital preparedness.
-
News‘Lawnmower-like’ viruses change up after dry soils are watered
Viruses in soil may not be as destructive to bacteria as once thought and could instead act like lawnmowers, culling older cells and giving space for new growth.
-
NewsResilience approach proposed for accurate diagnosis of HBV-related diseases
Chronic hepatitis B virus (HBV) infection poses a significant threat to global public health, contributing to liver-related morbidity and mortality. The current diagnostic methods for HBV-related diseases, such as laboratory tests, ultrasounds, computed tomography (CT), and liver biopsies, often overlap and consume valuable medical resources. In response to this challenge, ...
-
NewsCovid-linked sepsis more common and deadly than previously thought
New research suggests that the virus responsible for COVID-19 was a more common and deadly cause of sepsis during the initial period of the pandemic than previously assumed.
-
NewsNew coronavirus-capturing material could transform the face mask
Researchers have developed a new material that captures coronavirus particles and could transform the efficiency of face masks.
-
NewsHERV-W virus acting as neuropathogen successfully confirmed
Scientists have described a direct functional connection between the release of an endogenous retrovirus and the worsening of neurodegenerative processes in multiple sclerosis.
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
OpinionMuch ado about microbes
A group of leading scientists has recently reviewed the benefits and risks of Gain of Function research and issued new consensus recommendations - Simon Wain-Hobson examines the report exclusively for The Microbiologist.
-
NewsNanoparticles made from plant viruses could be farmers’ new ally
Engineers have developed nanoparticles, fashioned from plant viruses, that can deliver pesticide molecules to soil depths that were previously unreachable.
-
NewsAssays for rapid and visual detection of monkey B virus
Two recombinase polymerase amplification (RPA) assays have been developed for Monkey B virus that target two conserved genes combined with a one-off, closed visualization strip device
-
NewsNanoparticle vaccine candidate shows promise against emerging tick-borne virus
Researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that has no prevention, treatment or cure.
-
NewsDiscovery in mosquitoes could lead to new strategy against dengue fever
Researchers have discovered that a protein in the mosquito Aedes aegypti , Argonaute 2, has a key role - via several biological mechanisms - in keeping mosquitoes healthy and active despite the presence of viral infections like dengue and Zika.